-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EtgMEsf4jn0iJon7ot+3Yh/pZ7ka8YcN1TV0nBkXbOJWWfuRFe/zC/CcrXcVr+0m
 HOpwTnx8QqsmMAdYX8835g==

<SEC-DOCUMENT>0000909567-05-001281.txt : 20050811
<SEC-HEADER>0000909567-05-001281.hdr.sgml : 20050811
<ACCEPTANCE-DATETIME>20050811140607
ACCESSION NUMBER:		0000909567-05-001281
CONFORMED SUBMISSION TYPE:	RW
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20050811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viventia Biotech Inc.
		CENTRAL INDEX KEY:			0001316606
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		RW
		SEC ACT:		
		SEC FILE NUMBER:	001-32538
		FILM NUMBER:		051016363

	BUSINESS ADDRESS:	
		STREET 1:		10 FOUR SEASONS PLACE
		STREET 2:		SUITE 501
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M9B 6H7
		BUSINESS PHONE:		416-291-1277

	MAIL ADDRESS:	
		STREET 1:		10 FOUR SEASONS PLACE
		STREET 2:		SUITE 501
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M9B 6H7
</SEC-HEADER>
<DOCUMENT>
<TYPE>RW
<SEQUENCE>1
<FILENAME>t17659rw.txt
<DESCRIPTION>RW
<TEXT>
<PAGE>

TORYS LLP [LOGO]                        237 Park Avenue        Daniel M. Miller
- -----                                   New York, New York     Direct Tel.
NEW YORK   TORONTO                      10017.3142             212.880.6079
                                                               dmiller@torys.com
                                        TEL 212.880.6000
                                        FAX 212.682.0200

                                        www.torys.com


                                        August 11, 2005


Mr. Jeffrey Riedler
Assistant Director
United States Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549


 Re: Viventia Biotech Inc. Application for Withdrawal of Registration Statement
     on Form 20-F (File No. 001-32538)
     ---------------------------------------------------------------------------

Dear Mr. Riedler:

         On June 17, 2005 Viventia Biotech Inc. (the "Company"), filed with the
SEC a registration statement on Form 20-F in connection with its intention to
become listed on the American Stock Exchange.

         The Company is no longer pursuing a listing on the American Stock
Exchange at this time. Therefore, the Company requests that its Registration
Statement on Form 20-F be withdrawn.

         If you have any questions concerning this request, please call the
undersigned at (212) 880-6079.


                                                      Yours truly,

                                                      /s/ Daniel M. Miller
                                                      --------------------------
                                                      Daniel M. Miller

AHS

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----